Yuanzhen Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yuanzhen Lin has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Bin Geng
State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Beijing, China
1 shared publication - Changting Cui
Department of Emergency Medicine, Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
1 shared publication Dan Lou
Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China; Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Wenzhou 325027, China
1 shared publicationGuangyong Lin
Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China; Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Wenzhou 325027, China
1 shared publicationHailin Zhang
Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Wenzhou 325027, China; Department of Children's Respiration Disease, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
1 shared publication- Haizeng Zhang
Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Disease, Capital Medical University, Beijing, China (Z.C., H.Z., Q.Y., L.F., Q.L., X.G., F.Y., J. Cui, Y.T., J. Cai)
1 shared publication
Latest Publications
- Open Access
- 4 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Chromobox 3 assembles an epigenetic complex contributing to cystathionine γ-lyase–mediated protection against aortic aneurysm/dissection
Hydrogen sulfide (H₂S), generated by cystathionine γ-lyase (CSE), protects against aortic aneurysm and dissection (AAD), yet its role in extracellular matrix (ECM) regulation remains unclear. Here, we demonstrate that CSE expression is markedly attenuated in vascular smooth muscle cells (VSMCs) from human AAD specimens and AngII-induced male murine models. VSMC-specific Cse deletion exacerbated AAD formation. Mechanistically, Cse deficiency downregulated CBX3, thereby relieving transcriptional repression of Adamts4. Cbx3 overexpression rescued the aggravated AAD phenotype in Cse-deficient male mice. We further identified a CBX3-centered epigenetic complex (SUV39H1, KDM2A, HDAC1, RING1) that coordinates H3K9/4 methylation and acetylation to regulate ECM remodeling, apoptosis and inflammation-related genes. Notably, CSE/H₂S induced CBX3 sulfhydration at C69, C160, and C177, enhancing protein stability by reducing ubiquitin-mediated degradation; Therapeutically, AAV-mediated Cse or Cbx3 delivery via an extravascular carrier attenuated AAD incidence and progression in male mice. Collectively, these findings define a VSMCs CSE/H₂S-CBX3 epigenetic axis that constrains AAD through regulation of the ADAMTS4-versican pathway.
- 4 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessChromobox 3 assembles an epigenetic complex contributing to cystathionine γ-lyase–mediated protection against aortic aneurysm/dissection
Hydrogen sulfide (H₂S), generated by cystathionine γ-lyase (CSE), protects against aortic aneurysm and dissection (AAD), yet its role in extracellular matrix (ECM) regulation remains unclear. Here, we demonstrate that CSE expression is markedly attenuated in vascular smooth muscle cells (VSMCs) from human AAD specimens and AngII-induced male murine models. VSMC-specific Cse deletion exacerbated AAD formation. Mechanistically, Cse deficiency downregulated CBX3, thereby relieving transcriptional repression of Adamts4. Cbx3 overexpression rescued the aggravated AAD phenotype in Cse-deficient male mice. We further identified a CBX3-centered epigenetic complex (SUV39H1, KDM2A, HDAC1, RING1) that coordinates H3K9/4 methylation and acetylation to regulate ECM remodeling, apoptosis and inflammation-related genes. Notably, CSE/H₂S induced CBX3 sulfhydration at C69, C160, and C177, enhancing protein stability by reducing ubiquitin-mediated degradation; Therapeutically, AAV-mediated Cse or Cbx3 delivery via an extravascular carrier attenuated AAD incidence and progression in male mice. Collectively, these findings define a VSMCs CSE/H₂S-CBX3 epigenetic axis that constrains AAD through regulation of the ADAMTS4-versican pathway.
- 1 February 2021
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 33, 127728
ATB0,+-targeted delivery of triptolide prodrugs for safer and more effective pancreatic cancer therapy
- 1 February 2021
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 33, 127728
ATB0,+-targeted delivery of triptolide prodrugs for safer and more effective pancreatic cancer therapy